알레르기 비염의 침 치료에 대한 경제성 평가 연구 경향 분석
A Review of Economic Evaluations in Acupuncture for Allergic Rhinitis
2
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
Objective : The purpose of this study is to analyze research trends on the cost-effectiveness in acupuncture for patients with allergic rhinitis. Methods : The literature and research in allergic rhinitis was searched in electronic databases, such as National Health Service Economic Evaluation Database(NHS EED) and the Cochrane Database of Systematic Reviews(CDSR). The general characteristics and the results of each economic analysis such as incremental cost-effectiveness ratios(ICERs) were extracted. Results : In total, thirty seven studies were searched, and two studies were analyzed. They were cost-utility analysis(CUA)s that measured quality-adjusted life years(QALYs). One study showed that the ICER was €22,798 per QALY and was robust in sensitivity analysis. Another showed that the ICER was between €31,241 and €118,889 from society's perspective and between €20,807 and €74,585 from a third-party payer's perspective. Conclusions : Any generalization of these results needs to be made with caution given the specific effects of acupuncture and the difference of cost data in the various countries. Further studies are needed on this topic in order to demonstrate the cost-effectiveness clearly.
Abstract
Objective : The purpose of this study is to analyze research trends on the cost-effectiveness in acupuncture for patients with allergic rhinitis. Methods : The literature and research in allergic rhinitis was searched in electronic databases, such as National Health Service Economic Evaluation Database(NHS EED) and the Cochrane Database of Systematic Reviews(CDSR). The general characteristics and the results of each economic analysis such as incremental cost-effectiveness ratios(ICERs) were extracted. Results : In total, thirty seven studies were searched, and two studies were analyzed. They were cost-utility analysis(CUA)s that measured quality-adjusted life years(QALYs). One study showed that the ICER was €22,798 per QALY and was robust in sensitivity analysis. Another showed that the ICER was between €31,241 and €118,889 from society's perspective and between €20,807 and €74,585 from a third-party payer's perspective. Conclusions : Any generalization of these results needs to be made with caution given the specific effects of acupuncture and the difference of cost data in the various countries. Further studies are needed on this topic in order to demonstrate the cost-effectiveness clearly.
참고문헌 (27)
- 김철우, "알레르기 비염의 최신 지견", 대한내과학회지, 82(3), pp.298~303 (2012), 대한내과학회
- Ng ML, "Preliminary criteria for the definition of allergic rhinitis : a systematic evaluation of clinical parameters in a disease cohort(I)", Clin Exp Allergy, 30, pp.1314~1331 (2000)
- National Health Insurance Statistical Annual Report, "Korea National Health Insurance Service and Korea Health Insurance Review and Assessment Services", ~ (2014)
- Salib RJ, "Safety and tolerability profiles of intranasal antihistamines and intranasal corticosteroids in the treatment of allergic rhinitis", Drug Safe, 26, pp.863~893 (2003)
- Krouse JH, "Patient use of traditional and complementary therapies in treating rhinosinusitis before consulting an otolaryngologist", Laryngoscope, 109(8), pp.1223~1227 (1999)
- Scha¨fer T, "Alternative medicine in allergies—revalence, patterns of use, and costs", Allergy, 57(8), pp.694~700 (2002)
- Xue CC, "Acupuncture for persistent allergic rhinitis : a randomised, sham-controlled trial", Med J Aust, 187(6), pp.337~341 (2007)
- Choi SM, "A multicenter, randomized, controlled trial testing the effects of acupuncture on allergic rhinitis", Allergy, 68(3), pp.365~374 (2013)
- 김철민, "일차의료에서 보건경제학과 성과분석", Korean Journal of Family Medicine, 30(8), pp.577~587 (2009), 대한가정의학회
- Herman PM, "Are complementary therapies and integrative care cost-effective? A systematic review of economic evaluations", BMJ Open, 2(5) (2012)
- Park BJ, "Evidence-based Healthcare", ~ (2009)
- Drummond FM, "Methods for the Economic Evaluation of Health Care Programmes", Oxford, ~ (2015)
- Witt CM, "Cost-effectiveness of acupuncture in women and men with allergic rhinitis: a randomized controlled study in usual care", Am J Epidemiol, 169(5), pp.562~571 (2009)
- Reinhold T, "Cost-effectiveness for acupuncture in seasonal allergic rhinitis:economic results of the ACUSAR trial", Ann Allergy Asthma Immunol, 111(1), pp.56~63 (2013)
- Health Insurance Review Agency, "Guidelines for Economic Evaluation of Pharmaceuticals in Korea", ~ (2006)
- Eisenberg DM, "Unconventional medicine in the United States : prevalence, costs, and patterns of use", N Engl J Med, 328, pp.246~252 (1993)
- Eisenberg DM, "Trends in alternative medicine use in the United States, 1990–1997", JAMA, 280, pp.1569~1575 (1998)
- Barnes PM, "Advance data from Vital and Health Statistics", National Center for Health Statistics, ~ (2004)
- Costs of complementary and alternative medicine (CAM) and frequency of visits to CAM practitioners: United States, 2007. National Health Statistics Reports, "Nahin RL", National Center for Health Statistics, ~ (2009)
- Doran CM, "Review of economic methods used in complementary medicine", J Altern Complement Med, 16, pp.591~595 (2010)
- Kennedy DA, "Cost-effectiveness of natural health products : a systematic review of randomized clinical trials", Evid-Based Complement Altern Med, 6, pp.297~304 (2009)
- 장보형, "국내 한방병원의 알레르기 비염 환자 현황에 대한 탐색적 연구 - 3개 대학한방병원의 전자의무기록 자료를 중심으로", 한방안이비인후피부과학회지, 27(1), pp.117~129 (2014), 대한한방안이비인후피부과학회
- Pang F, "Design, analysis and presentation of multinational economic studies : the need for guidance", Pharmacoeconomics, 20(2), pp.75~90 (2002)
- National Institute for Clinical Excellence, "Guidance for Manufacturers and Sponsors. Technology Appraisals Process Series5", NICE, 6~ (2001)
- Fletcher A, "Quality of life measures in health care Ⅱ : design, analysis, and interpretation", BMJ, 305(7), pp.1145~1148 (1992)
- Canadian Coordination Office for Health Technology Assessment, "Guidelines for economic evaluation of pharmaceuticals", CCOHTA, ~ (1997)
- O'Brien BJ, "A tale of two (or more) cities:geographic transferability of pharmacoeconomic data", American Journal of Managed Care, 3(Suppl), pp.S33~S39 (1997)